[Treatment of hemophilia in children] NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Treatment of hemophilia in children]

Pediatr Med Chir. 1989 Nov-Dec;11(6):607-15. Unique Identifier : AIDSLINE MED/90259824
Stucchi C; Giovanniello A; Dozzi M; Careddu P; Carnelli V; Clinica Pediatrica I dell'Universita di Milano, Italia.

Abstract: Thanks to recent developments and evolution in prenatal diagnosis and early onset within the first year of life, hemophilia may now be considered a pathology of primarily pediatric interest. The treatment of hemophilia in children has furthermore undergone a number of changes that include 2 main events in therapy that have served to modify the quality of life of the hemophiliac. The first of these events regards blood products and the prevention of viral infections, hepatitis and HIV transmission. Prevention is based on various factors which include: donor selection, immunization, product testing and heat treatment of blood products. The second extremely important aspect of treatment in hemophilia is the concept of global assistance, which includes: the treatment of the bleeding episode itself, and an ongoing psycho-social support system. In this paper we suggest some practical treatment schedules for the therapy of bleeding episodes in addition to examining the severe side effects of HIV and Hepatitis viruses. The message which our paper attempts to transmit is that the hemophilic child must be ideally assisted in an exclusively pediatric environment.
Keywords: Acquired Immunodeficiency Syndrome/*TRANSMISSION Adolescence Blood Transfusion/*ADVERSE EFFECTS Child Child, Preschool English Abstract Factor VIII/ANTAGONISTS & INHIB/IMMUNOLOGY Hemophilia/DRUG THERAPY/IMMUNOLOGY/*THERAPY Hepatitis B/*TRANSMISSION Hepatitis C/*TRANSMISSION Hepatitis, Viral, Human/*TRANSMISSION Home Care Services Human Hypersensitivity, Immediate/*ETIOLOGY Infant Infant, Newborn Prognosis JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDacquiredimmunodeficiencysyndrome/KWDtransmissionadolescencebloodtransfusion/KWDadverseeffectschildchild,preschoolenglishabstractfactorviii/antagonists&inhib/immunologyhemophilia/drugtherapy/immunology/KWDtherapyhepatitisb/KWDtransmissionhepatitisc/KWDtransmissionhepatitis,viral,human/KWDtransmissionhomecareserviceshumanhypersensitivity,immediate/KWDetiologyinfantinfant,newbornprognosisjournalarticlereviewreview,tutorial
900830
M9080715

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .